Works matching IS 03407004 AND DT 2021 AND VI 70 AND IP 6

Results: 25
    1
    2

    Associations among cytokines, EGF and lymphocyte subpopulations in patients diagnosed with advanced lung cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1735, doi. 10.1007/s00262-020-02823-1
    By:
    • Suárez, Gisela María;
    • Añé-Kourí, Ana Laura;
    • González, Amnely;
    • Lorenzo-Luaces, Patricia;
    • Neninger, Elia;
    • Salomón, Eva Elena;
    • Cordero, Leamnet;
    • Catalá, Mauricio;
    • Ledón, Nuris;
    • Pereira, Karla;
    • Sánchez, Malkon Guillermo;
    • García, Beatriz;
    • Crombet, Tania;
    • Mazorra, Zaima;
    • Saavedra, Danay;
    • Lage, Agustin
    Publication type:
    Article
    3
    4

    The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterations.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1679, doi. 10.1007/s00262-020-02813-3
    By:
    • Willvonseder, Barbara;
    • Stögbauer, Fabian;
    • Steiger, Katja;
    • Jesinghaus, Moritz;
    • Kuhn, Peer-Hendrik;
    • Brambs, Christine;
    • Engel, Jutta;
    • Bronger, Holger;
    • Schmidt, Georg Philipp;
    • Haller, Bernhard;
    • Weichert, Wilko;
    • Keller, Gisela;
    • Noske, Aurelia;
    • Pfarr, Nicole;
    • Boxberg, Melanie
    Publication type:
    Article
    5

    A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1667, doi. 10.1007/s00262-020-02810-6
    By:
    • Del Re, Marzia;
    • Cucchiara, Federico;
    • Rofi, Eleonora;
    • Fontanelli, Lorenzo;
    • Petrini, Iacopo;
    • Gri, Nicole;
    • Pasquini, Giulia;
    • Rizzo, Mimma;
    • Gabelloni, Michela;
    • Belluomini, Lorenzo;
    • Crucitta, Stefania;
    • Ciampi, Raffaele;
    • Frassoldati, Antonio;
    • Neri, Emanuele;
    • Porta, Camillo;
    • Danesi, Romano
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    Circulating leukocyte–platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1691, doi. 10.1007/s00262-020-02793-4
    By:
    • Zamora, Carlos;
    • Riudavets, Mariona;
    • Anguera, Georgia;
    • Alserawan, Letícia;
    • Sullivan, Ivana;
    • Barba, Andrés;
    • Serra, Jorgina;
    • Ortiz, M. Angels;
    • Gallardo, Pablo;
    • Perea, Lidia;
    • Gavira, Javier;
    • Barnadas, Agustí;
    • Majem, Margarita;
    • Vidal, Silvia
    Publication type:
    Article
    13
    14
    15

    Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory "FoRECATT" study.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1583, doi. 10.1007/s00262-020-02788-1
    By:
    • Di Noia, Vincenzo;
    • D'Argento, Ettore;
    • Pilotto, Sara;
    • Vita, Emanuele;
    • Ferrara, Miriam Grazia;
    • Damiano, Paola;
    • Ribelli, Marta;
    • Cannella, Antonella;
    • Virtuoso, Antonella;
    • Fattorossi, Andrea;
    • Ceresoli, Giovanni Luca;
    • Milella, Michele;
    • Beretta, Giordano Domenico;
    • Tortora, Giampaolo;
    • Bria, Emilio
    Publication type:
    Article
    16
    17
    18

    Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1745, doi. 10.1007/s00262-020-02783-6
    By:
    • Takamori, Shinkichi;
    • Takada, Kazuki;
    • Shimokawa, Mototsugu;
    • Jinnnouchi, Mikako;
    • Matsubara, Taichi;
    • Haratake, Naoki;
    • Miura, Naoko;
    • Toyozawa, Ryo;
    • Yamaguchi, Masafumi;
    • Takenoyama, Mitsuhiro;
    • Yoneshima, Yasuto;
    • Tanaka, Kentaro;
    • Okamoto, Isamu;
    • Tagawa, Tetsuzo;
    • Mori, Masaki
    Publication type:
    Article
    19
    20

    Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1569, doi. 10.1007/s00262-020-02780-9
    By:
    • de Jong, G.;
    • Bartels, L.;
    • Kedde, M.;
    • Verdegaal, E. M. E.;
    • Gillissen, M. A.;
    • Levie, S. E.;
    • Cercel, M. G.;
    • van Hal-van Veen, S. E.;
    • Fatmawati, C.;
    • van de Berg, D.;
    • Yasuda, E.;
    • Claassen, Y. B.;
    • Bakker, A. Q.;
    • van der Burg, S. H.;
    • Schotte, R.;
    • Villaudy, J.;
    • Spits, H.;
    • Hazenberg, M. D.;
    • van Helden, P. M.;
    • Wagner, K.
    Publication type:
    Article
    21
    22
    23
    24
    25